Sarah Gheuens
Chief Tech/Sci/R&D Officer bij AGIOS PHARMACEUTICALS, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Sarah Gheuens is currently the Director at Viridian Therapeutics, Inc. since 2023.
She is also the Chief Medical Officer and Head of Research & Development at Agios Pharmaceuticals, Inc. since 2019.
In terms of education, Dr. Gheuens holds a doctorate degree from Vrije Universiteit Brussel, a graduate degree from Harvard Medical School, and another doctorate degree from the University of Antwerp.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-03-2024 | 39 066 ( 0.07% ) | 1 M $ | 31-03-2024 | |
| 21-09-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Sarah Gheuens
| Bedrijven | Functie | Begin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-09-2021 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 25-09-2023 |
Opleiding van Sarah Gheuens
| Vrije Universiteit Brussel | Doctorate Degree |
| Harvard Medical School | Graduate Degree |
| University of Antwerp | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
